Puma Biotech (PBYI) Posts Q2 adj.-Loss of $1.17/Share

Puma Biotech (NYSE: PBYI) reported Q2 EPS of ($1.17), $1.01 better than the analyst estimate of ($2.18).

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Lululemon (LULU) PT Lowered to $115 at Freedom Broker
• StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics